Offer - Urjas Oil for just ₹ 1
Amfirst 5 Tablet is a prescription medicine that is available as a Tablet. It is typically used for the treatment of High BP. Secondary and off-label uses of Amfirst 5 Tablet have also been mentioned below.
The correct dosage of Amfirst 5 Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Amfirst 5 Tablet can also lead to other problems, which have been listed below. Such side effects of Amfirst 5 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Amfirst 5 Tablet has a Severe effect for pregnant women and Unknown effect on lactating mothers. Warnings related to Amfirst 5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Amfirst 5 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Amfirst 5 Tablet in conditions like Low Blood Pressure (Hypotension), Coronary Artery Disease (CAD), Liver Disease. Other contraindications of Amfirst 5 Tablet have been discussed in the sections ahead.
Additionally, Amfirst 5 Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
You should also be aware that Amfirst 5 Tablet is safe while driving, and is addiction.
Amfirst 5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Amfirst 5 Tablet is used -
Moderate
Mild
Is the use of Amfirst 5 Tablet safe for pregnant women?
Amfirst shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Amfirst 5 Tablet safe during breastfeeding?
In the absence of any scientific study about the side effects of Amfirst in breastfeeding women, information on safety of Amfirst is unavailable.
What is the effect of Amfirst 5 Tablet on the Kidneys?
There may be some adverse effects on kidney after taking Amfirst. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Amfirst 5 Tablet on the Liver?
You may experience side effects on your liver after taking Amfirst. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Amfirst 5 Tablet on the Heart?
Amfirst is completely safe for the heart.
Amfirst 5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Amfirst 5 Tablet unless your doctor advises you to do so -
Is this Amfirst 5 Tablet habit forming or addictive?
Amfirst 5 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Amfirst 5 Tablet as it does not make you drowsy.
Is it safe?
Yes, but take Amfirst 5 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Amfirst 5 Tablet is not used to treat mental disorders.
Interaction between Food and Amfirst 5 Tablet
There isn't any research available on the side effects of taking Amfirst 5 Tablet with food.
Interaction between Alcohol and Amfirst 5 Tablet
Taking [medicine] and alcohol at the same time may lead to mild side effects. Contact your doctor right away if you observe any side effects.
No, Amfirst does not cause diabetes. It has not been reported to cause diabetes. However, Amfirst might increase your blood sugar levels slightly, healthy people can tolerate it easily while diabetic patients might face some spike in blood sugar levels. So, if you have diabetes keep a check on your blood sugar levels and in case of a sudden spike inform your doctor and take medicines accordingly.
No, use of Amfirst has not been associated with memory loss. But if you are in doubt do discuss with your doctor to check for underlying medical conditions resulting in memory loss.
Yes, you can take it with seafood safely if you are not allergic to seafood. However, there is a lot of scientific evidence that Amfirst has shown very strong interaction with grapefruit juice hence you are highly recommended to avoid grapefruit juice with this drug.
Rarely, Amfirst causes arrhythmia (Irregular heartbeat). However, if you experience any fluctuation in heart rate after consuming this drug, please inform to a doctor and follow his/her instructions.
Yes, Amfirst can cause edema. It is the most common side effects of this drug. Usually swelling occurs in feet and ankle. If these effects cause troublesome, then consult your doctor regarding whether this effect arises due to amlodipine consumption or not. If yes, then you can stop taking this medicine with the help of doctor because of alternate treatment are also available. However, it is dose-related effects if taken a low dose, chances of edema are very less if consuming high dose the chances of edema are high.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
